{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:15:54Z","timestamp":1790010954241,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12883-016-0663-7","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T14:03:56Z","timestamp":1471961036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study"],"prefix":"10.1186","volume":"16","author":[{"given":"Bernd","family":"Pohlmann-Eden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G.","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Noack-Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Tofighy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad J.","family":"Werhahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imane","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"key":"663_CR1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","volume":"34","author":"WA Hauser","year":"1993","unstructured":"Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935\u20131984. Epilepsia. 1993;34:453\u201368.","journal-title":"Epilepsia"},{"key":"663_CR2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.eplepsyres.2006.06.017","volume":"71","author":"M Sillanpaa","year":"2006","unstructured":"Sillanpaa M, Kalviainen R, Klaukka T, Helenius H, Shinnar S. Temporal changes in the incidence of epilepsy in Finland: nationwide study. Epilepsy Res. 2006;71:206\u201315.","journal-title":"Epilepsy Res"},{"key":"663_CR3","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1528-1167.2011.03186.x","volume":"52","author":"M Sillanpaa","year":"2011","unstructured":"Sillanpaa M, Lastunen S, Helenius H, Schmidt D. Regional differences and secular trends in the incidence of epilepsy in Finland: a nationwide 23-year registry study. Epilepsia. 2011;52:1857\u201367.","journal-title":"Epilepsia"},{"key":"663_CR4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrneurol.2009.74","volume":"5","author":"AM Arain","year":"2009","unstructured":"Arain AM, Abou-Khalil BW. Management of new-onset epilepsy in the elderly. Nat Rev Neurol. 2009;5:363\u201371.","journal-title":"Nat Rev Neurol"},{"key":"663_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1600-0404.2005.00508.x","volume":"181","author":"B Pohlmann-Eden","year":"2005","unstructured":"Pohlmann-Eden B. Issues when treating epilepsy in the elderly. Acta Neurol Scand Suppl. 2005;181:40\u20136.","journal-title":"Acta Neurol Scand Suppl"},{"key":"663_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1034\/j.1600-0404.108.s180.5.x","volume":"180","author":"E Trinka","year":"2003","unstructured":"Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol Scand Suppl. 2003;180:33\u20136.","journal-title":"Acta Neurol Scand Suppl"},{"key":"663_CR7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ane.12260","volume":"130","author":"JA Witt","year":"2014","unstructured":"Witt JA, Werhahn KJ, Kramer G, Ruckes C, Trinka E, Helmstaedter C. Cognitive-behavioral screening in elderly patients with new-onset epilepsy before treatment. Acta Neurol Scand. 2014;130:172\u20137.","journal-title":"Acta Neurol Scand"},{"key":"663_CR8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S1474-4422(09)70240-6","volume":"8","author":"MJ Brodie","year":"2009","unstructured":"Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol. 2009;8:1019\u201330.","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"663_CR9","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.eplepsyres.2005.07.019","volume":"68","author":"IE Leppik","year":"2006","unstructured":"Leppik IE, Brodie MJ, Saetre ER, Rowan AJ, Ramsay RE, Macias F, et al. Outcomes research: clinical trials in the elderly. Epilepsy Res. 2006;68 Suppl 1:S71\u20136.","journal-title":"Epilepsy Res"},{"key":"663_CR10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/ane.12218","volume":"129","author":"H Stefan","year":"2014","unstructured":"Stefan H, May TW, Pfafflin M, Brandt C, Furatsch N, Schmitz B, et al. Epilepsy in the elderly: comparing clinical characteristics with younger patients. Acta Neurol Scand. 2014;129:283\u201393.","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 1","key":"663_CR11","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.eplepsyres.2005.07.016","volume":"68","author":"J Cloyd","year":"2006","unstructured":"Cloyd J, Hauser W, Towne A, Ramsay R, Mattson R, Gilliam F, et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res. 2006;68 Suppl 1:S39\u201348.","journal-title":"Epilepsy Res"},{"issue":"3C","key":"663_CR12","first-page":"S195","volume":"6","author":"G Bergey","year":"2006","unstructured":"Bergey G, Birnbaum AK, Caserta FM, Ferrendelli JA, French JA, Leppik I. Diagnosis and treatment selection in elderly patients with epilepsy. Adv Stud Med. 2006;6(3C):S195\u2013209.","journal-title":"Adv Stud Med"},{"key":"663_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.yebeh.2005.11.007","volume":"8","author":"LJ Stephen","year":"2006","unstructured":"Stephen LJ, Kelly K, Mohanraj R, Brodie MJ. Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav. 2006;8:434\u20137.","journal-title":"Epilepsy Behav"},{"issue":"Suppl 1","key":"663_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1528-1167.2006.00664.x","volume":"47","author":"IE Leppik","year":"2006","unstructured":"Leppik IE. Epilepsy in the elderly. Epilepsia. 2006;47 Suppl 1:65\u201370.","journal-title":"Epilepsia"},{"key":"663_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1086-5802(16)31256-6","volume":"41","author":"SV Bourdet","year":"2001","unstructured":"Bourdet SV, Gidal BE, Alldredge BK. Pharmacologic management of epilepsy in the elderly. J Am Pharm Assoc (Wash). 2001;41:421\u201336.","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"663_CR16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","volume":"43","author":"PN Patsalos","year":"2002","unstructured":"Patsalos PN, Froscher W, Pisani F, Van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia. 2002;43:365\u201385.","journal-title":"Epilepsia"},{"key":"663_CR17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.56.2.4","volume":"56","author":"AJ Mclean","year":"2004","unstructured":"Mclean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56:163\u201384.","journal-title":"Pharmacol Rev"},{"key":"663_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","volume":"57","author":"PA Routledge","year":"2004","unstructured":"Routledge PA, O\u2019Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol. 2004;57:121\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"663_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","volume":"54","author":"MJ Brodie","year":"2013","unstructured":"Brodie MJ, Mintzer S, Pack AM, Gidal BE, Vecht CJ, Schmidt D. Enzyme induction with antiepileptic drugs: Cause for concern? Epilepsia. 2013;54:11\u201327.","journal-title":"Epilepsia"},{"key":"663_CR20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/01.wnl.0000341789.77291.8d","volume":"72","author":"BE Gidal","year":"2009","unstructured":"Gidal BE, French JA, Grossman P, Le Teuff G. Assessment of potential drug interactions in patients with epilepsy: impact of age and sex. Neurology. 2009;72:419\u201325.","journal-title":"Neurology"},{"key":"663_CR21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1532-5415.2010.02732.x","volume":"58","author":"MJ Pugh","year":"2010","unstructured":"Pugh MJ, Vancott AC, Steinman MA, Mortensen EM, Amuan ME, Wang CP, et al. Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications. J Am Geriatr Soc. 2010;58:465\u201371.","journal-title":"J Am Geriatr Soc"},{"key":"663_CR22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S1474-4422(15)00229-X","volume":"14","author":"S Mintzer","year":"2015","unstructured":"Mintzer S, French JA, Perucca E, Cramer JA, Messenheimer JA, Blum DE, et al. Is a separate monotherapy indication warranted for antiepileptic drugs? Lancet Neurol. 2015;14:1229\u201340.","journal-title":"Lancet Neurol"},{"key":"663_CR23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","volume":"54","author":"T Glauser","year":"2013","unstructured":"Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kalviainen R, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54:551\u201363.","journal-title":"Epilepsia"},{"key":"663_CR24","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.62.5_suppl_2.S24","volume":"62","author":"RE Ramsay","year":"2004","unstructured":"Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology. 2004;62:S24\u20139.","journal-title":"Neurology"},{"key":"663_CR25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/jnnp-2011-300376","volume":"84","author":"E Trinka","year":"2013","unstructured":"Trinka E, Marson AG, Van PW, Kalviainen R, Marovac J, Duncan B, et al. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy. J Neurol Neurosurg Psychiatry. 2013;84:1138\u201347.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"663_CR26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369:1000\u201315.","journal-title":"Lancet"},{"key":"663_CR27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369:1016\u201326.","journal-title":"Lancet"},{"key":"663_CR28","unstructured":"United Nations Department of Economic and Social Affairs Population Division. World Population Ageing 2013. ST\/ESA\/SER.A\/348 edition; 2013;1\u2013114. Retrieved from: http:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WorldPopulationAgeing2013.pdf ."},{"key":"663_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1474-4422(05)70172-1","volume":"4","author":"E Olafsson","year":"2005","unstructured":"Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol. 2005;4:627\u201334.","journal-title":"Lancet Neurol"},{"key":"663_CR30","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/01.WNL.0000167384.68207.3E","volume":"64","author":"AJ Rowan","year":"2005","unstructured":"Rowan AJ, Ramsay RE, Collins JF, Pryor F, Boardman KD, Uthman BM, et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005;64:1868\u201373.","journal-title":"Neurology"},{"key":"663_CR31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/epi.12926","volume":"56","author":"KJ Werhahn","year":"2015","unstructured":"Werhahn KJ, Trinka E, Dobesberger J, Unterberger I, Baum P, Deckert-Schmitz M, et al. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015;56:450\u20139.","journal-title":"Epilepsia"},{"key":"663_CR32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00002512-200320020-00005","volume":"20","author":"LJ Stephen","year":"2003","unstructured":"Stephen LJ. Drug treatment of epilepsy in elderly people: focus on valproic acid. Drugs Aging. 2003;20:141\u201352.","journal-title":"Drugs Aging"},{"key":"663_CR33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0404.2006.00668.x","volume":"184","author":"E Perucca","year":"2006","unstructured":"Perucca E, Aldenkamp A, Tallis R, Kramer G. Role of valproate across the ages. Treatment of epilepsy in the elderly. Acta Neurol Scand Suppl. 2006;184:28\u201337.","journal-title":"Acta Neurol Scand Suppl"},{"key":"663_CR34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.seizure.2012.09.012","volume":"22","author":"DP Huber","year":"2013","unstructured":"Huber DP, Griener R, Trinka E. Antiepileptic drug use in Austrian nursing home residents. Seizure. 2013;22:24\u20137.","journal-title":"Seizure"},{"key":"663_CR35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","volume":"2","author":"PN Patsalos","year":"2003","unstructured":"Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol. 2003;2:347\u201356.","journal-title":"Lancet Neurol"},{"key":"663_CR36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11940-010-0080-y","volume":"12","author":"C Lopinto-Khoury","year":"2010","unstructured":"Lopinto-Khoury C, Mintzer S. Antiepileptic drugs and markers of vascular risk. Curr Treat Options Neurol. 2010;12:300\u20138.","journal-title":"Curr Treat Options Neurol"},{"key":"663_CR37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.21615","volume":"65","author":"S Mintzer","year":"2009","unstructured":"Mintzer S, Skidmore CT, Abidin CJ, Morales MC, Chervoneva I, Capuzzi DM, et al. Effects of antiepileptic drugs on lipids, homocysteine, and C-reactive protein. Ann Neurol. 2009;65:448\u201356.","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"663_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2008.01445.x","volume":"49","author":"B Pohlmann-Eden","year":"2008","unstructured":"Pohlmann-Eden B, Newton M. First seizure: EEG and neuroimaging following an epileptic seizure. Epilepsia. 2008;49 Suppl 1:19\u201325.","journal-title":"Epilepsia"},{"key":"663_CR39","unstructured":"Pohlmann-Eden B, Crocker C, Legg K, Schmidt M. Epilepsy syndrome, MRI pathologies and treatment response in patients with first seizure and new-onset epilepsy-a comparison of patients of middle age (50-60 years) versus elderly patients (> older 60 years). Abstract No 2.171, 2014, American Epilepsy Society Annual Meeting, www.aesnet.org ."},{"key":"663_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(99)00039-X","volume":"37","author":"MJ Brodie","year":"1999","unstructured":"Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res. 1999;37:81\u20137.","journal-title":"Epilepsy Res"},{"key":"663_CR41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(01)00271-6","volume":"46","author":"M Nieto-Barrera","year":"2001","unstructured":"Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001;46:145\u201355.","journal-title":"Epilepsy Res"},{"key":"663_CR42","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1528-1167.2007.01128.x","volume":"48","author":"E Saetre","year":"2007","unstructured":"Saetre E, Perucca E, Isojarvi J, Gjerstad L. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia. 2007;48:1292\u2013302.","journal-title":"Epilepsia"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0663-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T03:50:13Z","timestamp":1589687413000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0663-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0663-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,23]]},"article-number":"149"}}